MLXIPL and steatosis: Knockdown of ChREBP prevents fructose-induced steatosis in mice, but ChREBP systemic knockout mice are intolerant to HFrD, have reduced expression of fat synthases such as fatty acid synthase, increased glycogen content, and develop features of liver injury 36.